Paradigm automates OTC trading within chat for institutional traders
Paradigm was born out of our own frustrations with the institutional OTC trading process. After spending hundreds of hours trading and navigating the inefficient, multi-channel nature of traditional OTC markets, we thought to ourselves: “there has to be a better way.” Paradigm is that better way. We are building the next generation of institutional OTC trading that is powered by conversation and automated with AI. We are backed by XBTO Ventures, Vectr Fintech Partners and some of the most influential private investors in the OTC markets.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 9, 2021 | Series A | $35M | 17 | Alameda Ventures | — | Detail |
Jul 1, 2020 | Seed | — | 5 | Dragonfly | — | Detail |
Jun 1, 2018 | Seed | $1.65M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Alameda Ventures | Yes | Series A |
Digital Currency Group | — | Series A |
GSR | — | Series A |
QCP Capital | — | Series A |
BitDAO | — | Series A |
Akuna Capital | — | Series A |
Avon Ventures | — | Series A |
Babel Finance | — | Series A |
CMT Digital Ventures | — | Series A |
Dragonfly | — | Series A |